Molecular Biology Pharma Companies Small Molecule 
Drug Discovery World
MAY 1, 2024
This is reflected in collaboration and investment patterns; in 2023, Antiverse, a biotechnology company developing a computational antibody drug discovery platform, raised seed funding totalling £1.4 These enable researchers to better manipulate biological molecules or identify the best candidates to progress to the next stage of development.
Drug Discovery World
APRIL 3, 2023
Also, the large, immunogenic nature of antibodies and protein ligands as therapeutic molecules means our partners are looking for alternative solutions that offer reduced immunogenicity and improved tissue penetration properties. Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
APRIL 19, 2024
Sibylla’s scientific founders come from very different scientific fields that do not usually speak to each other, such as theoretical physics, molecular biology and pharmaceutical chemistry. And so, I have been the managerial co-founder and CEO of Sibylla since 2017. This multidisciplinary approach is at the heart of Sibylla.
Elrig
APRIL 29, 2024
Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader. There, I supported AI-enabled DD efforts in their small molecule portfolio. big pharma or startups/spin off? Bioinformatics is all about bringing together different areas of knowledge.
Drug Discovery World
NOVEMBER 15, 2022
As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . Dr Leproust continues: “More and more therapeutic antibodies are being discovered from antibody libraries.
Expert insights. Personalized for you.
147 
Let's personalize your content